In the wake of the Trump deal, the GLP-1 market is poised to evolve with broader adoption of oral formulations, ongoing price competition, and more payer-level formulary adjustments that will influence long-term affordability and access
However, patients may notice changes in urination patterns due to improved blood sugar control, concurrent medications like SGLT2 inhibitors, or unrelated medical conditions
Because compounded formulations may have different absorption profiles than branded alternatives, working with a provider experienced in individualized GLP-1 therapy helps ensure proper monitoring, dose adjustments, and management of adverse effects throughout your treatment course
It is important for providers to constantly screen and assess both motor and nonmotor symptoms to appropriately adjust therapies
Hydration: GLP-1 medications can sometimes lead to dehydration because you may feel less thirsty